FCS hematologists and medical oncologists are presenting the findings of state-of-the-art breast cancer research conducted at FCS during the 2023 San Antonio Breast Cancer Symposium® this week.
Research conducted by FCS was featured this week at an international symposium devoted entirely to the development and use of immunotherapies against cancer.
FCS is pleased to welcome radiation oncologist Bradford Perez, MD to the statewide practice. He is providing care to patients at the FCS Trinity Cancer Center at 9320 State Road 54, Trinity, FL 34655.
FCS announced today the promotion of two members of its executive and physician leadership team. David Wenk, MD was appointed by the FCS Executive Board to serve as Assistant Managing Physician (AMP), effective January 1, 2024. Ken Sturtz has been appointed as Chief Information & Administrative Officer effective immediately.
Medical oncologist Lucio N. Gordan MD, president and managing physician of FCS, is lead author of the first real-world study comparing the two preferred regimens recommended for the primary treatment of non-transplant patients with newly-diagnosed multiple myeloma, published recently in Science Direct.
FCS Top News Updates
FCS Real-World Evidence Abstract Highlights Progress and Gaps in Biomarker Testing for Lung Cancer
FCS Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience